BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 11313689)

  • 1. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
    Graber CJ; de Almeida KN; Atkinson JC; Javaheri D; Fukuda CD; Gill VJ; Barrett AJ; Bennett JE
    Bone Marrow Transplant; 2001 Mar; 27(5):537-42. PubMed ID: 11313689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation.
    Bilgrami S; Feingold JM; Dorsky D; Edwards RL; Clive J; Tutschka PJ
    Bone Marrow Transplant; 1998 Mar; 21(6):591-5. PubMed ID: 9543063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.
    Castagnola E; Faraci M
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):607-21. PubMed ID: 19485800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
    Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study.
    Jaffe D; Jakubowski A; Sepkowitz K; Sebti R; Kiehn TE; Pamer E; Papanicolaou GA
    Clin Infect Dis; 2004 Dec; 39(11):1625-32. PubMed ID: 15578362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients.
    Gassas A; Grant R; Richardson S; Dupuis LL; Doyle J; Allen U; Abla O; Sung L
    J Clin Oncol; 2004 Apr; 22(7):1222-7. PubMed ID: 15051769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.
    Marron A; Carratalà J; González-Barca E; Fernández-Sevilla A; Alcaide F; Gudiol F
    Clin Infect Dis; 2000 Nov; 31(5):1126-30. PubMed ID: 11073739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections caused by viridans streptococci in patients with neutropenia.
    Tunkel AR; Sepkowitz KA
    Clin Infect Dis; 2002 Jun; 34(11):1524-9. PubMed ID: 12015700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of clarithromycin in preventing viridans streptococcal bacteremia following autologous stem cell transplantation.
    Naqvi B; Dorsky D; Ali SA; Feingold JM; Edwards RL; Bona RD; Clive J; Tutschka PJ; Bilgrami S
    Infection; 2001 Aug; 29(4):201-4. PubMed ID: 11545480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
    Ahmed R; Hassall T; Morland B; Gray J
    Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.
    Razonable RR; Litzow MR; Khaliq Y; Piper KE; Rouse MS; Patel R
    Clin Infect Dis; 2002 Jun; 34(11):1469-74. PubMed ID: 12015693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
    Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
    Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fever and neutropenia in pediatric hematopoietic stem cell transplant patients.
    Mullen CA; Nair J; Sandesh S; Chan KW
    Bone Marrow Transplant; 2000 Jan; 25(1):59-65. PubMed ID: 10654016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course.
    Avery R; Kalaycio M; Pohlman B; Sobecks R; Kuczkowski E; Andresen S; Mossad S; Shamp J; Curtis J; Kosar J; Sands K; Serafin M; Bolwell B
    Bone Marrow Transplant; 2005 Mar; 35(5):497-9. PubMed ID: 15640812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients.
    Almyroudis NG; Fuller A; Jakubowski A; Sepkowitz K; Jaffe D; Small TN; Kiehn TE; Pamer E; Papanicolaou GA
    Transpl Infect Dis; 2005 Mar; 7(1):11-7. PubMed ID: 15984943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis.
    Kersun LS; Propert KJ; Lautenbach E; Bunin N; Demichele A
    Pediatr Blood Cancer; 2005 Aug; 45(2):162-9. PubMed ID: 15593235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective evaluation of the area over the neutrophil curve index to predict early infection in hematopoietic stem cell transplantation recipients.
    Kimura S; Oshima K; Sato K; Sato M; Terasako K; Nakasone H; Kikuchi M; Okuda S; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Nishida J; Kanda Y
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1355-61. PubMed ID: 20457267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.
    Morecki S; Gelfand Y; Nagler A; Or R; Naparstek E; Varadi G; Engelhard D; Akerstein A; Slavin S
    Bone Marrow Transplant; 2001 Aug; 28(3):243-9. PubMed ID: 11535991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.